|
Dr. Lee Simon, MD - Associate Clinical Professor, Harvard Medical School, Former Division Director, Arthritis, Analgesic & Opthalmologic Drug Product Division, FDA
Dr. Simon is currently an Associate Clinical Professor at Harvard Medical School. Previously, Dr. Simon was with the FDA where he was the Division Director of the Arthritis, Analgesic and Ophthalmologic Drug Product Division. Prior to his tenure at the FDA, Dr. Simon was Director of Rheumatology Clinical Research and as Associate Chief of Medicine at Beth Israel Deaconess Medical Center in Boston, MA. Dr. Simon attended Loyola College and received his medical degree from the University of Maryland, School of Medicine.
|
Dr. William K. Schmidt, Ph.D. - President, NorthStar Consulting and Senior VP of Development at Limerick BioPharma
Dr. Schmidt is currently the Head of NorthStar Consulting, LLC and Senior VP of Development at Limerick BioPharma in South San Francisco, CA. Dr. Schmidt was previously VP, Clinical Research, for Renovis, Inc. Prior to this, Dr. Schmidt served as VP, Scientific Affairs, at Adolor Corporation. Dr. Schmidt is the Immediate Past-President of the Eastern Pain Association. He has over 25 years of pharmaceutical industry experience with a special emphasis on the discovery and development of novel analgesic and narcotic antagonist drugs. Dr. Schmidt received his Ph.D. in Pharmacology from the University of California, San Francisco. Following his postdoctoral fellowship at Boston University, School of Medicine, Dr. Schmidt was a researcher at DuPont Pharmaceuticals (later the DuPont Merck Pharmaceutical Company) where he helped to develop nalbuphine (Nubain®), naltrexone (Trexan®, ReVia®) and the oxycodone-ibuprofen formulation used in Combunox™. |
Dr. Sunil Panchal, MD - President, National Institute of Pain
Dr. Sunil J. Panchal currently is President of the National Institute of Pain, and President of the COPE (Coalition for Pain Education) Foundation, a not-for-profit educational foundation. Dr. Panchal was most recently Associate Professor in the Departments of Oncology and Anesthesiology and Director of Interventional Pain Medicine at the H. Lee Moffitt Cancer Center and Research Institute of the University of South Florida, College of Medicine. Previously he served as Co-Director of the Chronic Pain Service as well as Director of the Multidisciplinary Pain Fellowship Training Program at Johns Hopkins University and subsequently as Director, Division of Pain Medicine at the Joan and Sanford I. Weill Medical College of Cornell University. Dr. Panchal received his medical degree from Albany Medical College of Union University in Albany, New York. He also completed the Business of Medicine Graduate Program at Johns Hopkins University. |
|
